Current smokers have increased risk for reporting classic symptoms, more than five symptoms, more than 10 symptoms
One-Third of U.S. Adults Likely to Refuse a COVID-19 Vaccine
Blacks, women, and conservatives more hesitant in the United States
Stem Cell Infusions Investigated for Treatment of COVID-19 ARDS
Researchers explore possible anti-inflammatory effects of mesenchymal stem cells in COVID-19 acute respiratory distress syndrome
Higher Dietary Fiber Lowers Premenopausal Depression Risk
Significant association between dietary fiber intake and prevalence of depression seen for premenopausal, but not postmenopausal, women
Stopping RAS Inhibitors May Worsen Outcomes in CKD
Stopping therapy tied to lower risk for dialysis, but higher risk for cardiovascular events and death
Physician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Jan. 11 to 15, 2021. This …
Breast, Cervical, CRC Screening Below Healthy People 2020 Targets
Colorectal cancer test receipt near target in 2018, with 66.9 percent of adults aged 50 to 75 years up to date with testing
WHO Experts Finally Arrive in Wuhan for COVID-19 Investigation
First known cases of the novel coronavirus appeared in the city more than a year ago
A 1% glycopyrronium bromide cream for the topical treatment of primary axillary hyperhidrosis: Efficacy and Safety Results from a Phase 3a Randomised Controlled Study.
Effective topical treatment options for patients with primary axillary hyperhidrosis are limited. Recent phase 1 trial showed promising results regarding efficacy and safety for topical cream containing glycopyrronium bromide (GPB).To …
U.S. COVID-19 Vaccine Rollout Nears 1 Million Doses Per Day
News comes as Ohio State University researchers discover new variant of COVID-19 virus